Similar articles

• In vitro activity of penicillin G/sulbactam compared with penicillin and other antibiotics against common organisms causing ear, nose and throat (ENT) infections.

  Wenzler S, Schmidt-Eisenlohr E, Daschner F. Wenzler S, et al. J Antimicrob Chemother. 2003 May;51(5):1312-4. doi: 10.1093/jac/dkg215. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697651 No abstract available.
• Timentin--clinical and pharmacokinetic evaluation in otorhinolaryngology.

  Federspil P, Koch A, Schätzle W, Tiesler E. Federspil P, et al. J Antimicrob Chemother. 1986 May;17 Suppl C:103-13. doi: 10.1093/jac/17.suppl_c.103. J Antimicrob Chemother. 1986. PMID: 3722042
• The penicillins.

  Barr NL Jr. Barr NL Jr. Ear Nose Throat J. 1981 May;60(5):215-8. Ear Nose Throat J. 1981. PMID: 6908856 No abstract available.
• Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment.

  Smith A, Buchinsky FJ, Post JC. Smith A, et al. Otolaryngol Head Neck Surg. 2011 Mar;144(3):338-47. doi: 10.1177/0194599810391620. Epub 2011 Jan 24. Otolaryngol Head Neck Surg. 2011. PMID: 21493193 Review.
• Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

  Friedel HA, Campoli-Richards DM, Goa KL. Friedel HA, et al. Drugs. 1989 Apr;37(4):491-522. doi: 10.2165/00003495-198937040-00005. Drugs. 1989. PMID: 2661196 Review.